. A. Tabarin, . S. Bardet, . J. Bertherat, C. B. Dupas, and . Hamoir, Exploration and management of adrenal incidentalomas., Annales d'Endocrinologie, vol.69, issue.6, pp.487-500, 2008.
DOI : 10.1016/j.ando.2008.09.003

. Chidiac, A. D. Rm, and . Incidentalomas, A disease of modern technology

. C. Davenport, . A. Liew, W. B. Doherty, . Hh, . H. Misran et al., The prevalence of adrenal incidentaloma in routine clinical practice, Endocrine, vol.54, issue.6, pp.80-83, 2011.
DOI : 10.1007/s12020-011-9445-6

. Young and . Wf, The Incidentally Discovered Adrenal Mass, New England Journal of Medicine, vol.356, issue.6, pp.601-611, 2007.
DOI : 10.1056/NEJMcp065470

. L. Barzon, . N. Sonino, . F. Fallo, . G. Palu, and . M. Boscaro, Prevalence and natural history of adrenal incidentalomas, European Journal of Endocrinology, vol.149, issue.4, pp.273-285, 2003.
DOI : 10.1530/eje.0.1490273

. G. Mansmann, . J. Lau, . E. Balk, . M. Rothberg, . Y. Miyachi et al., The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management, Endocrine Reviews, vol.25, issue.2, pp.309-349, 2004.
DOI : 10.1210/er.2002-0031

. F. Mantero, . M. Terzolo, and . Arnaldi, A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology, J Clin Endocrinol Metab, vol.85, issue.2, pp.637-681, 2000.

A. B. Bulow, Adrenal incidentaloma - experience of a standardized diagnostic programme in the Swedish prospective study, Journal of Internal Medicine, vol.29, issue.3, pp.239-285, 2002.
DOI : 10.1001/jama.248.6.701

. R. Rossi, . L. Tauchmanova, D. A. Luciano, . M. Martino, D. C. Battista et al., Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features, J Clin Endocrinol Metab, vol.85, issue.4, pp.1440-1448, 2000.

. Y. Aso and . Homma, A survey on incidental adrenal tumors in Japan, Journal of Urology, vol.147, pp.1478-1481, 1992.

. Herrera, . Mf, . Grant, . Cs, . Van-heerden et al., Incidentally discovered adrenal tumors: an institutional perspective, Surgery, vol.110, pp.1014-1021, 1991.

. L. Barzon, . F. Fallo, . N. Sonino, and . M. Boscaro, Development of overt Cushing's syndrome in patients with adrenal incidentaloma, European Journal of Endocrinology, vol.146, issue.1, pp.61-66, 2002.
DOI : 10.1530/eje.0.1460061

. P. Franceschetti, Evaluation of hormonal function in a series of incidentally discovered adrenal masses, Metabolism, vol.46, pp.107-113, 1997.

. Linos, . Da, . N. Stylopoulos, . Raptis, and . Sa, Adrenaloma: a call for a more aggressive management, World Journal of Surgery, vol.20, pp.788-793, 1996.

. M. Murai, . S. Baba, and T. J. Nakashima, Management of incidentally discovered adrenal masses, World Journal of Urology, vol.17, issue.1, pp.9-14, 1999.
DOI : 10.1007/s003450050098

. Kloss, . Rt, . Gross, F. Md, . Ir et al., Incidentally discovered adrenal masses, Endocrine reviews, vol.16, pp.460-479, 1995.

. A. Leroy-willig, . J. Bittoun, . Luton, . Jp, . A. Louvel et al., In vivo MR spectroscopic imaging of the adrenal glands: distinction between adenomas and carcinomas larger than 15 mm based on lipid content, American Journal of Roentgenology, vol.153, issue.4, pp.771-774, 1989.
DOI : 10.2214/ajr.153.4.771

. Blake, . Ma, . Kalra, . Mk, . Sweeney et al., Distinguishing Benign from Malignant Adrenal Masses: Multi???Detector Row CT Protocol with 10-Minute Delay, Radiology, vol.238, issue.2, pp.578-85, 2006.
DOI : 10.1148/radiol.2382041514

. Lee, . Mj, . Hahn, . Pf, and . Papanicolaou, Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis., Radiology, vol.179, issue.2, pp.415-423, 1991.
DOI : 10.1148/radiology.179.2.2014283

. Van-erkel, . Ar, . Van-gils, . Ap, . M. Lequin et al., CT and MR Distinction of Adenomas and Nonadenomas of the Adrenal Gland, Journal of Computer Assisted Tomography, vol.18, issue.3, pp.432-440, 1994.
DOI : 10.1097/00004728-199405000-00017

. H. Miyake, . H. Takaki, Y. S. Matsumoto, . T. Maeda, and . H. Mori, Adrenal nonhyperfunctioning adenoma and nonadenoma: CT attenuation value as discriminative index, Abdominal Imaging, vol.15, issue.6, pp.559-62, 1995.
DOI : 10.1007/BF01256711

. Outwater, . Ek, . Siegelman, . Es, . Huang et al., Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences., Radiology, vol.200, issue.3, pp.749-52, 1996.
DOI : 10.1148/radiology.200.3.8756926

. Szolar, . Dh, and . Kammerhuber, Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas?, Radiology, vol.202, issue.2, pp.517-538, 1997.
DOI : 10.1148/radiology.202.2.9015083

. Boland, . Gw, . Hahn, . Pf, . C. Pena et al., Adrenal masses: characterization with delayed contrast-enhanced CT., Radiology, vol.202, issue.3, pp.693-699, 1997.
DOI : 10.1148/radiology.202.3.9051018

. Hamrahian, . Ah, . Ioachimescu, . Ag, . Remer et al., Clinical Utility of Noncontrast Computed Tomography Attenuation Value (Hounsfield Units) to Differentiate Adrenal Adenomas/Hyperplasias from Nonadenomas: Cleveland Clinic Experience, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.2, pp.871-878, 2005.
DOI : 10.1210/jc.2004-1627

. Boland, L. Gw, . Mj, . Gazelle, . Gs et al., Characterization of Adrenal Masses Using Unenhanced CT, The Journal of Urology, vol.171, issue.1, pp.201-205, 1998.
DOI : 10.1097/00005392-199901000-00122

. Caoili, . Em, F. M. Korobkin, and . Ir, Adrenal Masses: Characterization with Combined Unenhanced and Delayed Enhanced CT, Radiology, vol.222, issue.3, pp.629-633, 2002.
DOI : 10.1148/radiol.2223010766

. Ramsay, A. Ja, . Sl, . Van-nostrand, . Aw et al., Lipid Degeneration in Pheochromocytomas Mimicking Adrenal Cortical Tumors, The American Journal of Surgical Pathology, vol.11, issue.6, pp.480-486, 1987.
DOI : 10.1097/00000478-198706000-00009

. Blake, . Ma, . Krishnamoorthy, . Sk, . Boland et al., A Mimicker of Adrenal Adenoma, American Journal of Roentgenology, vol.181, issue.6, pp.1663-1671, 2003.
DOI : 10.2214/ajr.181.6.1811663

. Qiao, . Zw, . Xia, . Cm, . Zhu et al., First-pass perfusion computed tomography: Initial experience in differentiating adrenal adenoma from metastasis, European Journal of Radiology, vol.73, issue.3, pp.657-663, 2010.
DOI : 10.1016/j.ejrad.2009.01.007

. Haider, . Ma, . S. Ghai, and L. K. Jhaveri, Chemical Shift MR Imaging of Hyperattenuating (>10 HU) Adrenal Masses: Does It Still Have a Role?, Radiology, vol.231, issue.3, pp.711-717, 2004.
DOI : 10.1148/radiol.2313030676

. Bilbey, . Jh, . Mcloughlin, . Rf, . Kurkjian et al., MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors., American Journal of Roentgenology, vol.164, issue.3
DOI : 10.2214/ajr.164.3.7863885

. Outwater, . Ek, . Siegelman, . Es, . Radecki et al., Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging., American Journal of Roentgenology, vol.165, issue.3, pp.579-83, 1995.
DOI : 10.2214/ajr.165.3.7645474

. Reinig, . Jw, . Stutley, . Je, . Leonhardt et al., Differentiation of adrenal masses with MR imaging: comparison of techniques., Radiology, vol.192, issue.1, pp.41-47, 1994.
DOI : 10.1148/radiology.192.1.8208962

. M. Korobkin, . Lombardi, . Tj, . Aisen, and . Am, Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging., Radiology, vol.197, issue.2, pp.411-419, 1995.
DOI : 10.1148/radiology.197.2.7480685

. Israel, . Gm, W. M. Korobkin, . Hecht, . En et al., Comparison of Unenhanced CT and Chemical Shift MRI in Evaluating Lipid-Rich Adrenal Adenomas, American Journal of Roentgenology, vol.183, issue.1
DOI : 10.2214/ajr.183.1.1830215

. Faria, . Jf, . Goldman, . Sm, and . J. Szejnfeld, Adrenal Masses: Characterization with in Vivo Proton MR Spectroscopy???Initial Experience, Radiology, vol.245, issue.3, pp.788-797, 2007.
DOI : 10.1148/radiol.2453061854

. Gross, . Md, . B. Shapiro, . Bouffard, and . Ja, Distinguishing Benign from Malignant Euadrenal Masses, Mis à jour le 21 septembre 2011, pp.613-621, 1988.
DOI : 10.7326/0003-4819-109-8-613

. Gross, . Md, F. B. Shapiro, and . Ir, Scintigraphic evaluation of clinically silent adrenal masses, J Nucl Med, vol.35, issue.7, pp.1145-52, 1994.

. L. Barzon, . C. Scaroni, . N. Sonino, . F. Fallo, . A. Paoletta et al., Risk Factors and Long-Term Follow-Up of Adrenal Incidentalomas, Journal of Clinical Endocrinology & Metabolism, vol.84, issue.2, pp.520-526, 1999.
DOI : 10.1210/jc.84.2.520

. Boland, . Gw, . Dwamena, J. Ba, and . M. Sangwaiya, Characterization of Adrenal Masses by Using FDG PET: A Systematic Review and Meta-Analysis of Diagnostic Test Performance, Radiology, vol.259, issue.1, pp.117-126, 2011.
DOI : 10.1148/radiol.11100569

. Nunes, . Ml, . A. Rault, and . J. Teynie, 18F-FDG PET for the Identification of Adrenocortical Carcinomas among Indeterminate Adrenal Tumors at Computed Tomography Scanning, World Journal of Surgery, vol.238, issue.7, pp.1506-1510, 2010.
DOI : 10.1007/s00268-010-0576-3

. S. Leboulleux, . D. Deandreis, and . Escourrou, Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy, European Journal of Endocrinology, vol.164, issue.1, pp.89-941605, 2006.
DOI : 10.1530/EJE-10-0666

. Nieman, . Lk, and . Ilias, Evaluation and treatment of Cushing???s syndrome, The American Journal of Medicine, vol.118, issue.12, pp.1340-1346, 2005.
DOI : 10.1016/j.amjmed.2005.01.059

. R. Ravichandran, . F. Lafferty, . Mcginniss, . Mj, . Taylor et al., Congenital adrenal hyperplasia presenting as massive adrenal incidentalomas in the sixth decade of life: report of two patients with 21-hydroxylase deficiency, J Clin Endocrinol Metab, vol.81, issue.5, pp.1776-1785, 1996.

S. T. Seppel, Augmented 17??-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas'), Clinical Endocrinology, vol.91, issue.4, pp.445-51, 1994.
DOI : 10.1210/jc.75.3.826

. G. Abiven, . J. Coste, and . Groussin, Clinical and Biological Features in the Prognosis of Adrenocortical Cancer: Poor Outcome of Cortisol-Secreting Tumors in a Series of 202 Consecutive Patients, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.7, pp.2650-2655, 2006.
DOI : 10.1210/jc.2005-2730

. I. Chiodini, Diagnosis and Treatment of Subclinical Hypercortisolism, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.5, pp.1223-1236, 2011.
DOI : 10.1210/jc.2010-2722

. M. Terzolo, . S. Bovio, and . Reimondo, Subclinical Cushing's Syndrome in Adrenal Incidentalomas, Endocrinology and Metabolism Clinics of North America, vol.34, issue.2, pp.423-462, 2005.
DOI : 10.1016/j.ecl.2005.01.008

. M. Terzolo, Subclinical Cushing's syndrome in adrenal incidentaloma, Clinical Endocrinology, vol.121, issue.1, pp.89-97, 1998.
DOI : 10.1210/jc.81.2.740

. M. Terzolo, . A. Stigliano, . I. Chiodini, . P. Loli, . L. Furlani et al., AME Position Statement on adrenal incidentaloma, European Journal of Endocrinology, vol.164, issue.6, pp.851-870, 2011.
DOI : 10.1530/EJE-10-1147

A. G. Reimondo, S. S. Bovio, . A. Ardito, and . Angeli, Pros and cons of dexamethasone suppression test for screening of subclinical Cushing???s syndrome in patients with adrenal incidentalomas, Journal of Endocrinological Investigation, vol.30, issue.1, pp.1-5, 2011.
DOI : 10.1007/BF03346701

H. Anthropometric, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery, Eur J Endocrinol. Feb, vol.148, issue.2, pp.213-222, 2003.

. L. Tauchmanovà, . R. Rossi, . B. Biondi, . M. Pulcrano, . V. Nuzzo et al., Patients with Subclinical Cushing???s Syndrome due to Adrenal Adenoma Have Increased Cardiovascular Risk, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.11, pp.4872-4880, 2002.
DOI : 10.1210/jc.2001-011766

. M. Tsuiki, . A. Tanabe, . S. Takagi, and T. M. Naruse, Cardiovascular Risks and Their Long-Term Clinical Outcome in Patients with Subclinical Cushing's Syndrome, Endocrine Journal, vol.55, issue.4
DOI : 10.1507/endocrj.K07E-177

D. G. Dalmazi, . V. Vicennati, . E. Rinaldi, . Morselli-labate, . Am et al., Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study, European Journal of Endocrinology, vol.166, issue.4, pp.669-677, 2012.
DOI : 10.1530/EJE-11-1039

P. M. Terzolo, . A. Alì, . G. Osella, . G. Reimondo, and . Bovio, Adrenal Incidentaloma: A New Cause of the Metabolic Syndrome?, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.3, pp.998-1003, 2002.
DOI : 10.1210/jcem.87.3.8277

. M. Debono, . A. Prema, . Hughes, . Tj, R. M. Bull et al., Visceral Fat Accumulation and Postdexamethasone Serum Cortisol Levels in Patients With Adrenal Incidentaloma, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.6, pp.2383-2391, 2013.
DOI : 10.1210/jc.2012-4276

. I. Chiodini, . V. Morelli, . Salcuni, . As, . C. Eller-vainicher et al., Beneficial Metabolic Effects of Prompt Surgical Treatment in Patients with an Adrenal Incidentaloma Causing Biochemical Hypercortisolism, The Journal of Clinical Endocrinology & Metabolism, vol.95, issue.6, pp.2736-2745, 2010.
DOI : 10.1210/jc.2009-2387

. A. Toniato, . I. Merante-boschin, . G. Opocher, . Pelizzo, . Mr et al., Surgical Versus Conservative Management for Subclinical Cushing Syndrome in Adrenal Incidentalomas: A Prospective Randomized Study, Annals of Surgery, vol.249, issue.3, pp.388-391, 2009.
DOI : 10.1097/SLA.0b013e31819a47d2

. Y. Erbil, . E. Ademo?lu, . N. Ozbey, Y. U. Barbaros, . Bt et al., Evaluation of the Cardiovascular Risk in Patients with Subclinical Cushing Syndrome Before and After Surgery, World Journal of Surgery, vol.7, issue.9, pp.1665-1671, 2006.
DOI : 10.1007/s00268-005-0681-x

. M. Debono, . R. Chadarevian, R. R. Eastell, . Rj, . J. Newell-price et al., Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot study Subclinical Cushing's syndrome, PLoS One. Pituitary, vol.8, issue.74, pp.217-240, 2004.

. Garrapa, . Gg, . P. Pantanetti, . G. Arnaldi, and F. F. Mantero, Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome, J Clin Endocrinol Metab, vol.86, issue.11, pp.5301-5307, 2001.

. Fernández-real, . Jm, . Engel, . Wr, . R. Simó et al., Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours, Clinical Endocrinology, vol.60, issue.1, pp.53-61, 1998.
DOI : 10.1016/S0140-6736(85)92964-2

M. M. Ivovi?, . Lv, . S. Vujovi?, . M. Tan?i?-gaji?, . M. Stojanovi? et al., Nondiabetic patients with either subclinical Cushing's or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: Clinical implications, Metabolism, vol.62, issue.6, pp.786-92, 2013.
DOI : 10.1016/j.metabol.2012.12.006

. Anderwald, . Ch, . A. Tura, . A. Gessl, . A. Luger et al., Adequately Adapted Insulin Secretion and Decreased Hepatic Insulin Extraction Cause Elevated Insulin Concentrations in Insulin Resistant Non-Diabetic Adrenal Incidentaloma Patients, PLoS ONE, vol.18, issue.10, p.77326, 2013.
DOI : 10.1371/journal.pone.0077326.t002

. S. Midorikawa, . H. Sanada, . S. Hashimoto, . T. Suzuki, and . Watanabe, The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection, Clinical Endocrinology, vol.43, issue.6
DOI : 10.1210/jc.81.2.740

. J. Vandwalle, Syndrome de Cushing infra-clinique : impact de la surrénalectomie sur les paramètres métaboliques pré-opératoires, 2010.

. Dackiw, L. Ap, . Je, . Gagel, . Rf et al., Adrenal cortical carcinoma, World Journal of Surgery, vol.12, issue.7, pp.914-940, 2001.
DOI : 10.1007/s00268-001-0030-7

. P. Iacconi, . C. Bendinelli, . P. Miccoli, . Bernini, and . Gp, RE, The Journal of Urology, vol.161, issue.5, pp.1580-1581, 1999.
DOI : 10.1097/00005392-199905000-00053

. Schteingart, . De, . Doherty, . Gm, . Gauger et al., Management of patients with adrenal cancer: recommendations of an international consensus conference, Endocrine Related Cancer, vol.12, issue.3
DOI : 10.1677/erc.1.01029

. Thompson, . Gb, . Grant, . Cs, . Van-heerden et al., Laparoscopic versus open posterior adrenalectomy: A case-control study of 100 patients, Surgery, vol.122, issue.6, pp.1132-1138, 1997.
DOI : 10.1016/S0039-6060(97)90218-X

. Winfield, H. Hn, . Bd, . Bravo, . El et al., LAPAROSCOPIC ADRENALECTOMY, The Journal of Urology, vol.160, issue.2, pp.325-334, 1998.
DOI : 10.1097/00005392-199808000-00006

. G. Guazzoni, . A. Cestari, . F. Montorsi, . R. Lanzi, . L. Nava et al., Eightyear experience with transperitoneal laparoscopic adrenal surgery, J Urol, 2001.

. D. Emeriau, . V. Vallee, . P. Tauzin-fin, and . P. Ballanger, Morbidity of unilateral and bilateral laparoscopic adrenalectomy according to the indication Report of a series of 100 consecutive cases, Prog Urol, vol.15, issue.4, pp.626-657, 2005.

. Palazzo, . Ff, . F. Sebag, . M. Sierra, . G. Ippolito et al., Long-term Outcome following Laparoscopic Adrenalectomy for Large Solid Adrenal Cortex Tumors, World Journal of Surgery, vol.157, issue.5, pp.893-901, 2006.
DOI : 10.1007/s00268-005-0288-2

. K. Suzuki, . S. Kageyama, . Y. Hirano, . T. Ushiyama, and F. S. Rajamahanty, COMPARISON OF 3 SURGICAL APPROACHES TO LAPAROSCOPIC ADRENALECTOMY, The Journal of Urology, vol.166, issue.2, pp.437-480, 2001.
DOI : 10.1097/00005392-200108000-00009

. K. Jeschke, . G. Janetschek, . R. Peschel, . L. Schellander, . G. Bartsch et al., Laparoscopic partial adrenalectomy in patients with aldosterone-producing adenomas: indications, technique, and results, Urology, vol.61, issue.1, pp.69-72, 2003.
DOI : 10.1016/S0090-4295(02)02240-9

. Bernini, . Gp, . A. Moretti, . C. Oriandini, . M. Bardini et al., Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas, British Journal of Cancer, vol.202, issue.6, pp.1104-1109, 2005.
DOI : 10.1097/00001622-200301000-00013

. M. Reincke, . M. Fasnachat, M. S. Vath, and A. B. , Incidentaloma, Adrenal, pp.757-761, 1996.
DOI : 10.1016/B0-12-475570-4/00747-2

. Andrews, . Rc, . Walker, and . Br, Glucocorticoids and insulin resistance: old hormones, new targets, Clinical Science, vol.96, issue.5, pp.513-523, 1999.
DOI : 10.1042/cs0960513

. M. Strubbs, . York, and . Da, Central regulation of parasympathic drive to pancreatic ?cells in the obese fa/fa rat, Int. J. Obes, vol.15, pp.547-553, 1991.

. F. Delaunay, . A. Khan, . A. Cintra, L. B. Davani, . Zc et al., Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids., Journal of Clinical Investigation, vol.100, issue.8, pp.2094-2102, 1997.
DOI : 10.1172/JCI119743

. H. Lefebvre, . C. Duparc, . G. Prevost, and . Louiset, Le dialogue intra-surrénalien dans les hypercorticismes: perspectives thérapeutiques. Conférence présentée aux trente-troisièmes journées Nicolas Guéritée d'endocrinologie et maladies métaboliques, 2013.

. H. Lefebvre, . C. Duparc, and . Chartrel, Intraadrenal Adrenocorticotropin Production in a Case of Bilateral Macronodular Adrenal Hyperplasia Causing Cushing???s Syndrome, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.7, pp.3035-3042, 2003.
DOI : 10.1210/jc.2002-030014

C. J. Bertherat and . Louiset, Screening for Illegitimate Receptors in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Causing Cushing???s Syndrome: Identification of Two Cases of Gonadotropin/Gastric Inhibitory Polypeptide-Dependent Hypercortisolism, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.3, pp.1302-1310, 2005.
DOI : 10.1210/jc.2004-1256

. M. Joubert, . E. Louiset, . Do-rego, and . Jl, Aberrant adrenal sensitivity to vasopressin in adrenal tumours associated with subclinical or overt autonomous hypercortisolism: is this explained by an overexpression of vasopressin receptors?, Clinical Endocrinology, vol.48, issue.5, pp.692-699, 2008.
DOI : 10.1210/jc.2002-030014

. M. Ehrhart-bornstein, . Hinson, . Jp, . Bornstein, and . Sr, Intraadrenal Interactions in the Regulation of Adrenocortical Steroidogenesis, Endocrine Reviews, vol.19, issue.2, pp.101-143, 1998.
DOI : 10.1210/edrv.19.2.0326

. Stewart and . Pm, Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action, European Journal of Endocrinology, vol.149, issue.3, pp.163-168, 2003.
DOI : 10.1530/eje.0.1490163

Y. Y. Wang, W. L. Liu, . H. Du, and . Fan, 11??-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue, AJP: Endocrinology and Metabolism, vol.308, issue.1, pp.84-95, 2015.
DOI : 10.1152/ajpendo.00205.2014

. T. Mune, . H. Morita, . T. Suzuki, . Y. Takahashi, . Y. Isomura et al., Role of Local 11??-Hydroxysteroid Dehydrogenase Type 2 Expression in Determining the Phenotype of Adrenal Adenomas, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.2, pp.864-870, 2003.
DOI : 10.1210/jc.2001-011335

D. Guia, R. Rm, . Aj, . A. Sommerfeld, . O. Seibert et al., microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis, The EMBO Journal, vol.34, issue.3, pp.344-60, 2015.
DOI : 10.15252/embj.201490464

. Bowles, . Np, . Karatsoreos, . In, . X. Li et al., A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome, Proceedings of the National Academy of Sciences, vol.112, issue.1, pp.285-90, 2015.
DOI : 10.1073/pnas.1421420112

V. I. Mertens and . Gaal, Obesity, haemostasis and the fibrinolytic system, Obesity Reviews, vol.19, issue.2, pp.85-101, 2002.
DOI : 10.1038/sj.ijo.0801087

. P. Vague, . D. Raccah, and . Scelles, Hypofibrinolysis and the insulin resistance syndrome, Int J Obes Relat Metab Disord, vol.19, issue.1, pp.11-16, 1995.

L. T. Skurk, . Ym, . K. Rohrig, and . H. Hauner, Effect of Angiotensin Peptides on PAI-1 Expression and Production in Human Adipocytes, Hormone and Metabolic Research, vol.33, issue.4, pp.196-200, 2001.
DOI : 10.1055/s-2001-14948

. Halleux, . Cm, . Declerck, . Pj, . Tran et al., Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholaminess, J Clin Endocrinol Metab, vol.84, issue.11, pp.4097-105, 1999.

. C. Erem, . I. Nuhoglu, . M. Yilmaz, . M. Kocak, . A. Demirel et al., Blood coagulation and fibrinolysis in patients with Cushing???s syndrome: Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels, Journal of Endocrinological Investigation, vol.22, issue.2, pp.169-74, 2009.
DOI : 10.1007/BF03345709

. L. Manetti, . F. Bogazzi, . C. Giovannetti, . V. Raffaelli, . M. Genovesi et al., Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery, European Journal of Endocrinology, vol.163, issue.5, pp.783-791, 2010.
DOI : 10.1530/EJE-10-0583

. D. Kastelan, . T. Dusek, . I. Kraljevic, . O. Polasek, . Z. Giljevic et al., Hypercoagulability in Cushing???s syndrome: the role of specific haemostatic and fibrinolytic markers, Endocrine, vol.87, issue.1, pp.70-74, 2009.
DOI : 10.1007/s12020-009-9186-y

. R. Van-der-pas, . De, . Bc, . Leebeek, . Fw et al., The Hypercoagulable State in Cushing's Disease Is Associated with Increased Levels of Procoagulant Factors and Impaired Fibrinolysis, But Is Not Reversible after Short-Term Biochemical Remission Induced by Medical Therapy, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.4, pp.1303-1310, 2012.
DOI : 10.1210/jc.2011-2753

. Patrassi, . Gm, . Sartori, . Mt, . Viero et al., The fibrinolytic potential in patients with Cushing??s disease, Blood Coagulation & Fibrinolysis, vol.3, issue.6, pp.789-793, 1992.
DOI : 10.1097/00001721-199212000-00013

. I. Juhan-vague, . Thompson, and J. J. Sg, Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris

. Jacoby, . Rc, . Owings, . Jt, . T. Ortega et al., Biochemical Basis for the Hypercoagulable State Seen in Cushing Syndrome, Archives of Surgery, vol.136, issue.9, pp.1003-1006, 2001.
DOI : 10.1001/archsurg.136.9.1003

. D. Graversen, . P. Vestergaard, . K. Stochholm, . Gravholt, . Ch et al., Mortality in Cushing's syndrome: A systematic review and meta-analysis, European Journal of Internal Medicine, vol.23, issue.3, pp.278-282, 2012.
DOI : 10.1016/j.ejim.2011.10.013

. Dekkers, . Om, . E. Horvath-puho, . Jorgensen, . Jo et al., Multisystem Morbidity and Mortality in Cushing's Syndrome: A Cohort Study, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.6, pp.2277-2284, 2013.
DOI : 10.1210/jc.2012-3582

. R. Van-der-pas, . Leebeekt, H. Fwg, . Lj, . De-herder et al., Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment, Clinical Endocrinology, vol.20, issue.10-12, pp.481-488, 2013.
DOI : 10.1111/cen.12094

. A. Isidori, . M. Minnetti, . E. Sbardella, . C. Graziadio, and . A. Grossman, The spectrum of haemostatic abnormalities in glucocorticoid excess and defect, Eur J Endocrinol. first published on, 2015.

. R. Swiatkowska-stodulska, . S. Kaniuka-jakubowska, . P. Wisniewski, . A. Skibowska-bielinska, and . K. Sworczak, The estimation of selected endogenous anticoagulation system parameters in patients with subclinical Cushing's syndrome, European Journal of Endocrinology, vol.165, issue.6, pp.865-871, 2011.
DOI : 10.1530/EJE-11-0535

. B. Ambrosi, . A. Sartorio, . A. Pizzocaro, . E. Passini, . B. Bottasso et al., Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma, Experimental and Clinical Endocrinology & Diabetes, vol.108, issue.4, pp.294-302, 2000.
DOI : 10.1055/s-2000-8000

. Ridker, . Pm, . Hennekens, . Ch, . Stampfer et al., Prospective study of endogenous tissue plasminogen activator and risk of stroke, The Lancet, vol.343, issue.8903, pp.940-943, 1994.
DOI : 10.1016/S0140-6736(94)90064-7

. E. Ernst, . Resch, and . Kl, Fibrinogen as a Cardiovascular Risk Factor, Annals of Internal Medicine, vol.118, issue.12, pp.956-963, 1993.
DOI : 10.7326/0003-4819-118-12-199306150-00008

. M. Debono, . M. Bradburn, and . Bull, Cortisol as a Marker for Increased Mortality in Patients with Incidental Adrenocortical Adenomas, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.12, p.20143007, 2014.
DOI : 10.1210/jc.2014-3007

. M. Reincke, Subclinical Cushing's syndrome. Endocrinology and metabolism Clinics of, North America, vol.29, pp.43-56, 2000.

. I. Chiodini, . V. Morelli, . B. Masserini, . Salcuni, . As et al., Bone Mineral Density, Prevalence of Vertebral Fractures, and Bone Quality in Patients with Adrenal Incidentalomas with and without Subclinical Hypercortisolism: An Italian Multicenter Study, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.9, pp.3207-3214, 2009.
DOI : 10.1210/jc.2009-0468

. J. Dallongeville, Epidémiologie du syndrome métabolique et du risque cardiovasculaire

. V. Morelli, . F. Donadio, and . C. Eller-vainicher, Role of glucocorticoid receptor polymorphism in adrenal incidentalomas, European Journal of Clinical Investigation, vol.32, issue.9, pp.803-814, 2010.
DOI : 10.1111/j.1365-2362.2010.02330.x

. Chiasson, J. Jl, . Rg, . R. Gomis, . M. Hanefeld et al., Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance, JAMA, vol.290, issue.4, pp.486-494, 2003.
DOI : 10.1001/jama.290.4.486

. S. Tsagarakis, . C. Roboti, . P. Kokkoris, A. V. Vasiliou, and T. N. , Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas, Clinical Endocrinology, vol.121, issue.2, pp.165-171, 1998.
DOI : 10.1046/j.1365-2265.1997.1580969.x

. S. Salahuddin and R. D. Prabhakaran, Pathophysiological Mechanisms of Tobacco-Related CVD. Glob Heart, pp.113-133, 2012.